Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -37.81%169.67M | -44.36%294.17M | -44.36%294.17M | 32.83%235.57M | -36.13%147.82M | 97.94%272.8M | 318.57%528.72M | 318.57%528.72M | 57.68%177.34M | 105.45%231.44M |
-Cash and cash equivalents | -37.81%169.67M | -44.34%294.17M | -44.34%294.17M | 32.83%235.57M | -36.13%147.82M | 97.94%272.8M | 318.40%528.51M | 318.40%528.51M | 57.68%177.34M | 105.45%231.44M |
-Money market investments | ---- | ---- | ---- | ---- | ---- | ---- | --215K | --215K | ---- | ---- |
Receivables | -3.36%38.66M | 2.68%39.75M | 2.68%39.75M | 4.01%39.37M | 15.20%43.24M | 9.83%40.01M | 9.68%38.71M | 9.68%38.71M | 25.76%37.85M | 29.45%37.54M |
-Accounts receivable | -3.36%38.66M | 2.68%39.75M | 2.68%39.75M | 4.01%39.37M | 15.20%43.24M | 9.83%40.01M | 9.68%38.71M | 9.68%38.71M | 25.76%37.85M | 29.45%37.54M |
Net loan | 6.38%4.86B | 11.30%4.86B | 11.30%4.86B | 10.23%4.75B | 13.02%4.77B | 8.78%4.57B | 6.22%4.37B | 6.22%4.37B | 8.82%4.31B | 8.61%4.22B |
-Gross loan | 6.36%4.91B | 11.21%4.91B | 11.21%4.91B | 10.18%4.81B | 12.92%4.83B | 8.70%4.62B | 6.13%4.42B | 6.13%4.42B | 8.66%4.36B | 8.44%4.27B |
-Allowance for loans and lease losses | 4.50%52.65M | 3.90%51.98M | 3.90%51.98M | 6.40%52.88M | 4.48%52.22M | 1.74%50.39M | -0.86%50.03M | -0.86%50.03M | -3.25%49.7M | -4.53%49.98M |
Securities and investments | -15.67%2.08B | -15.71%2.1B | -15.71%2.1B | -14.20%2.43B | -15.85%2.43B | -16.83%2.46B | -17.46%2.49B | -17.46%2.49B | -6.15%2.83B | -6.61%2.89B |
-Held to maturity securities | -4.25%1.84B | -4.01%1.87B | -4.01%1.87B | -3.97%1.89B | -3.99%1.9B | -4.46%1.93B | -3.81%1.95B | -3.81%1.95B | -3.20%1.97B | -3.37%1.98B |
-Short term investments | -56.77%231.43M | -57.30%233.68M | -57.30%233.68M | -37.45%541.17M | -41.81%527.05M | -43.26%535.32M | -45.14%547.25M | -45.14%547.25M | -12.22%865.17M | -12.99%905.81M |
Federal home loan bank stock | -15.63%45.41M | 55.98%53.83M | 55.98%53.83M | 55.98%53.83M | 55.98%53.83M | 66.83%53.83M | 29.36%34.51M | 29.36%34.51M | 29.36%34.51M | 29.36%34.51M |
Bank owned life insurance | 2.62%37.41M | 3.58%37.45M | 3.58%37.45M | -75.13%37.12M | -75.18%36.77M | -75.23%36.46M | -75.26%36.16M | -75.26%36.16M | 2.59%149.21M | 56.59%148.17M |
Net PPE | -0.85%93.5M | -0.76%93.86M | -0.76%93.86M | -1.24%93.54M | -1.43%93.7M | 2.71%94.3M | 2.06%94.58M | 2.06%94.58M | 2.56%94.72M | 1.36%95.05M |
-Gross PPE | ---- | 3.18%163.88M | 3.18%163.88M | ---- | ---- | ---- | 4.99%158.83M | 4.99%158.83M | ---- | ---- |
-Accumulated depreciation | ---- | -8.98%-70.01M | -8.98%-70.01M | ---- | ---- | ---- | -9.63%-64.24M | -9.63%-64.24M | ---- | ---- |
Goodwill and other intangible assets | -1.99%164.62M | -2.02%165.43M | -2.02%165.43M | -2.04%166.28M | -2.06%167.12M | -2.09%167.97M | -2.10%168.84M | -2.10%168.84M | -2.10%169.74M | -1.74%170.64M |
-Goodwill | 0.00%155.21M | 0.00%155.21M | 0.00%155.21M | 0.00%155.21M | 0.00%155.21M | 0.00%155.21M | 0.00%155.21M | 0.00%155.21M | 0.00%155.21M | 0.41%155.21M |
-Other intangible assets | -26.24%9.41M | -24.97%10.22M | -24.97%10.22M | -23.83%11.07M | -22.83%11.91M | -21.93%12.75M | -20.96%13.63M | -20.96%13.63M | -20.01%14.53M | -19.16%15.43M |
Other assets | -12.40%140.67M | -13.80%152.64M | -13.80%152.64M | -21.84%119.03M | 24.11%165.66M | 31.47%160.59M | 27.13%177.06M | 27.13%177.06M | -3.86%152.28M | 3.99%133.48M |
Total assets | -2.93%7.63B | -1.75%7.8B | -1.75%7.8B | -0.40%7.93B | -0.64%7.91B | -0.54%7.86B | 0.86%7.94B | 0.86%7.94B | 3.12%7.96B | 4.22%7.96B |
Liabilities | ||||||||||
Total deposits | 3.33%5.77B | -1.13%5.6B | -1.13%5.6B | 0.47%5.73B | -1.39%5.63B | -2.14%5.58B | -3.29%5.66B | -3.29%5.66B | -2.24%5.7B | -2.33%5.71B |
Federal funds purchased and securities sold under agreement to repurchase | --87.85M | -33.90%89.91M | -33.90%89.91M | ---- | ---- | ---- | -50.10%136.03M | -50.10%136.03M | ---- | ---- |
Payables | 45.69%11.44M | -49.94%11.14M | -49.94%11.14M | -29.98%11.4M | -11.77%11.24M | 32.61%7.85M | 313.55%22.25M | 313.55%22.25M | 730.24%16.28M | 430.35%12.74M |
-Accounts payable | 45.69%11.44M | -49.94%11.14M | -49.94%11.14M | -29.98%11.4M | -11.77%11.24M | 32.61%7.85M | 313.55%22.25M | 313.55%22.25M | 730.24%16.28M | 430.35%12.74M |
Long term debt and capital lease obligation | -37.13%925.52M | 39.53%1.26B | 39.53%1.26B | -6.41%1.38B | 0.15%1.47B | 3.09%1.47B | 21.23%899.82M | 21.23%899.82M | 26.53%1.47B | 36.58%1.47B |
-Long term debt | -37.13%925.52M | 39.53%1.26B | 39.53%1.26B | -6.41%1.38B | 0.15%1.47B | 3.09%1.47B | 21.23%899.82M | 21.23%899.82M | 26.53%1.47B | 36.58%1.47B |
Other liabilities | -21.01%58.98M | -83.90%80.31M | -83.90%80.31M | -27.31%55.95M | 15.98%74.1M | 25.23%74.66M | 57.25%498.68M | 57.25%498.68M | -0.02%76.97M | 6.24%63.89M |
Total liabilities | -3.99%6.85B | -2.55%7.04B | -2.55%7.04B | -1.29%7.17B | -0.94%7.19B | -0.85%7.13B | 0.37%7.22B | 0.37%7.22B | 2.72%7.27B | 3.88%7.25B |
Shareholders'equity | ||||||||||
Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Paid-in capital | 1.10%360.52M | 2.07%363.76M | 2.07%363.76M | 0.84%358.45M | 0.77%357.67M | 0.72%356.6M | 0.62%356.4M | 0.62%356.4M | 0.75%355.48M | 0.72%354.95M |
Retained earnings | 3.90%452.95M | 1.66%436.12M | 1.66%436.12M | -1.58%454.05M | -2.04%442.98M | -1.05%435.93M | -0.08%429.02M | -0.08%429.02M | 11.09%461.33M | 13.47%452.21M |
Gains losses not affecting retained earnings | 47.52%-37.41M | 45.50%-36.3M | 45.50%-36.3M | 53.27%-57.68M | 24.44%-73.99M | 22.55%-71.28M | 37.28%-66.61M | 37.28%-66.61M | -0.25%-123.43M | -5.22%-97.92M |
Total stockholders'equity | 7.60%776.06M | 6.23%763.58M | 6.23%763.58M | 8.86%754.82M | 2.46%726.67M | 2.66%721.25M | 6.12%718.81M | 6.12%718.81M | 7.50%693.37M | 7.81%709.24M |
Total equity | 7.60%776.06M | 6.23%763.58M | 6.23%763.58M | 8.86%754.82M | 2.46%726.67M | 2.66%721.25M | 6.12%718.81M | 6.12%718.81M | 7.50%693.37M | 7.81%709.24M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |